Promising but I think still a long way behind NEU. It'll be interesting to see how effective PYC's drug will be compared with NEU's NNZ2591. I understand they have 2 different ways of correcting the deficiency of the Shank3 protein. Which one will turn out to be more effective? NEU has already successfully completed Stage II trials in the US to test for safety and efficacy in affected children, but PYC still has to embark on Stage I trials to test for safety in healthy humans don't they? NEU could be starting Stage III registrational trials for 2591 in PMS next year. I hold shares in both companies, so there's no cross promotion here.
- Forums
- ASX - By Stock
- PYC
- Ann: PMS Drug Candidate Effective In Human Brain Cells
Ann: PMS Drug Candidate Effective In Human Brain Cells, page-6
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $956.5M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 19.3¢ | $758.0K | 3.815M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59988 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 589881 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59988 | 0.200 |
2 | 58708 | 0.195 |
6 | 228077 | 0.190 |
5 | 215366 | 0.185 |
7 | 254227 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 589881 | 5 |
0.210 | 1323580 | 10 |
0.215 | 1185250 | 4 |
0.220 | 1194571 | 3 |
0.225 | 128750 | 2 |
Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online